Global X HealthTech ETF (NASDAQ:HEAL) Short Interest Down 64.0% in June

Global X HealthTech ETF (NASDAQ:HEAL) saw a large drop in short interest in the month of June. As of June 30th, there was short interest totaling 13,534 shares, a drop of 64.0% from the June 15th total of 37,633 shares. Based on an average trading volume of 8,169 shares, the short-interest ratio is currently 1.7 days. Approximately 1.3% of the shares of the stock are sold short.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. WT Wealth Management grew its stake in Global X HealthTech ETF by 14.7% in the 1st quarter. WT Wealth Management now owns 101,116 shares of the company’s stock valued at $2,409,000 after acquiring an additional 12,945 shares during the last quarter. Citadel Advisors LLC acquired a new stake in shares of Global X HealthTech ETF in the third quarter valued at approximately $216,000. Flow Traders U.S. LLC purchased a new position in shares of Global X HealthTech ETF during the 3rd quarter worth approximately $368,000. Daiwa Securities Group Inc. acquired a new position in shares of Global X HealthTech ETF during the 3rd quarter worth approximately $11,239,000. Finally, Raymond James Financial Inc. purchased a new stake in Global X HealthTech ETF in the 3rd quarter valued at approximately $274,000.

Global X HealthTech ETF Price Performance

HEAL opened at $28.24 on Monday. Global X HealthTech ETF has a 1-year low of $23.00 and a 1-year high of $33.59. The stock has a market cap of $29.93 million, a P/E ratio of 42.80 and a beta of 1.10. The stock’s 50 day simple moving average is $26.01 and its 200 day simple moving average is $26.60.

About Global X HealthTech ETF

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.